ERYP.PA - ERYTECH Pharma S.A.

Paris - Paris Delayed Price. Currency in EUR
Currency in EUR
Earnings EstimateCurrent Qtr. (Dec 2017)Next Qtr. (Mar 2018)Current Year (2017)Next Year (2018)
No. of Analysts0000
Avg. Estimate0000
Low Estimate0000
High Estimate0000
Year Ago EPSN/AN/AN/AN/A
Revenue EstimateCurrent Qtr. (Dec 2017)Next Qtr. (Mar 2018)Current Year (2017)Next Year (2018)
No. of Analysts1065
Avg. EstimateN/AN/A3.36M5.02M
Low Estimate5MN/AN/AN/A
High Estimate5MN/A5M11M
Year Ago SalesN/AN/A4.14M3.36M
Sales Growth (year/est)N/AN/A-18.70%49.20%
Earnings HistoryInvalid DateInvalid DateInvalid DateInvalid Date
EPS Est.N/AN/AN/AN/A
EPS ActualN/AN/AN/AN/A
DifferenceN/AN/AN/AN/A
Surprise %N/AN/AN/AN/A
EPS TrendCurrent Qtr. (Dec 2017)Next Qtr. (Mar 2018)Current Year (2017)Next Year (2018)
Current Estimate0000
7 Days Ago-1.420-2.02-2.44
30 Days Ago-1.420-2.02-2.44
60 Days Ago-1.420-2.02-2.44
90 Days Ago-1.420-2.02-2.44
EPS RevisionsCurrent Qtr. (Dec 2017)Next Qtr. (Mar 2018)Current Year (2017)Next Year (2018)
Up Last 7 DaysN/AN/AN/A1
Up Last 30 DaysN/AN/AN/A1
Down Last 7 DaysN/AN/AN/AN/A
Down Last 30 DaysN/AN/AN/AN/A
Growth EstimatesERYP.PAIndustrySectorS&P 500
Current Qtr.N/AN/AN/A0.02
Next Qtr.N/AN/AN/A0.04
Current YearN/AN/AN/A0.05
Next YearN/AN/AN/A0.11
Next 5 Years (per annum)N/AN/AN/A0.10
Past 5 Years (per annum)N/AN/AN/AN/A